Patent details
EP3672591 Title: SYNERGISTIC ANTITUMOR EFFECT OF BCL-2 INHIBITOR COMBINED WITH RITUXIMAB AND/OR BENDAMUSTINE OR BCL-2 INHIBITOR COMBINED WITH CHOP
Basic Information
- Publication number:
- EP3672591
- PCT Application Number:
- CN2019097028
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP198454662
- PCT Publication Number:
- WO2020024826
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- SYNERGISTIC ANTITUMOR EFFECT OF BCL-2 INHIBITOR COMBINED WITH RITUXIMAB AND/OR BENDAMUSTINE OR BCL-2 INHIBITOR COMBINED WITH CHOP
- French Title of Invention:
- EFFET ANTITUMORAL SYNERGIQUE D'UN INHIBITEUR DE BCL-2 COMBINÉ AVEC DU RITUXIMAB ET/OU DE LA BENDAMUSTINE OU D'UN INHIBITEUR DE BCL-2 COMBINÉ À CHOP
- German Title of Invention:
- SYNERGISTISCHE ANTITUMORWIRKUNG EINES BCL-2-INHIBITORS IN KOMBINATION MIT RITUXIMAB UND/ODER BENDAMUSTIN ODER EINES BCL-2-INHIBITORS IN KOMBINATION MIT CHOP
- SPC Number:
Dates
- Filing date:
- 22/07/2019
- Grant date:
- 14/02/2024
- EP Publication Date:
- 01/07/2020
- PCT Publication Date:
- 06/02/2020
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 14/02/2024
- EP B1 Publication Date:
- 14/02/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 22/07/2024
- Expiration date:
- 22/07/2039
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 07/02/2024
- Name:
- Ascentage Pharma (Suzhou) Co., Ltd.
- Address:
- Unit 701, Building B7, 218 Xinghu Street Suzhou Industrial Park, Suzhou, Jiangsu 215000, China (CN)
Inventor
1
- Name:
- YANG, Dajun
- Address:
- China (CN)
2
- Name:
- WANG, Guangfeng
- Address:
- China (CN)
3
- Name:
- ZHAI, Yifan
- Address:
- China (CN)
Priority
- Priority Number:
- 201810867252
- Priority Date:
- 31/07/2018
- Priority Country:
- China (CN)
Classification
- IPC classification:
- A61K 31/4184; A61K 39/395;
Publication
European Patent Bulletin
- Issue number:
- 202407
- Publication date:
- 14/02/2024
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|